AltAssets is the private equity news and research service from Almeida Capital
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

PRINT THIS PAGE

AXA Framlington transfers six funds to newly formed Architas

07/07/2008Source: AltAssets.  

Hedge fund manager AXA Framlington has transferred the firm's six AXA Framlington Multimanager funds to newly formed hedge fund manager Architas Multi-Manager. As part of the deal, Caspar Rock has been appointed as deputy CIO of Architas. Rock will continue to manage the funds which he has been running since June 2006.

A member of AXA, Architas will operate as an independent multi-manager provider. The firm will complement AXA IM and AXA Framlington by supporting the broadening of AXA's proposition to include a move to an unbiased and guided architecture distribution model, according to the firm.

Alongside his portfolio management responsibilities, Rock will also work with Richard Philbin, the recently appointed CIO of Architas, on the development of new portfolio propositions.

The funds are: AXA Framlington Multimanager Reserve Fund, which has been renamed Architas MM Reserve Fund; AXA Framlington Multimanager Cautious Income Fund, renamed Architas MM Cautious Income Fund; AXA Framlington Multimanager Income Fund, renamed Architas MM Income Fund; AXA Framlington Multimanager Balanced Fund, renamed Architas MM Balanced Fund; AXA Framlington Multimanager Growth Fund, renamed Architas MM Growth Fund; and AXA Framlington Multimanager Dynamic Fund, renamed Architas MM Dynamic Fund.

Mike Kellard, CEO, Architas, said, 'We are very pleased that Caspar brings his strong track record with him to Architas as deputy CIO. The incorporation of the AXA Framlington Multimanager Funds within Architas is consistent with the focus and priorities of both of these investment companies in the UK.'

Rock was appointed head of investments AXA Framlington Multimanager in 2006. He joined the firm in 1995 as a European fund manager, transferring to the healthcare team in 2001 to manage the FIPS Health Fund and to research medical services, medical devices and pharmaceuticals.

AXA Framlington will continue to focus on the broadening of its distribution channels in the UK and internationally as well as growing its current core product range, according to the firm.

Copyright © 2008 AltAssets

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

All rights reserved. This document and its content are for your personal, non-commercial use only. No further copying, reproduction, distribution, transmission, display of AltAssets content is allowed. To obtain permission please contact editorial@altassets.com. You may not alter or remove the copyright or any other statements from copies of the content.

AltAssets is a service offered by Almeida Capital's Research Division. Available online at www.AltAssets.net
Almeida Capital Ltd is regulated by FSA and registered in England (no. 3945728). Registered Office: Acre House, 11-15 William Road, London NW1 3ER. Legals & Terms of Use
Content is © AltAssets 2000-2008

Subscribe to our newsletter Subscribe to our newsletter